Author:
Li Qinchen,Wang Zhize,Yi Jiahe,Shen Haixiang,Yang Zitong,Yan Libin,Xie Liping
Funder
National Natural Science Foundation of China
Reference56 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019
2. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens;Ylitalo;Prostate,2020
3. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions;Paller;Clin. Adv. Hematol. Oncol.,2013
4. AR-V7 protein expression in circulating tumour cells is not predictive of treatment response in mCRPC;Erb;Urol. Int.,2020
5. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer;Galletti;Cancer Treat. Rev.,2017